Discontinuation report MINT-RIZATRIPTAN ODT
Report ID | 13544 |
Drug Identification Number | 02439573 |
Brand name | MINT-RIZATRIPTAN ODT |
Common or Proper name | Rizatriptan Benzoate |
Company Name | MINT PHARMACEUTICALS INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | RIZATRIPTAN |
Strength(s) | 5MG |
Dosage form(s) | TABLET (ORALLY DISINTEGRATING) |
Route of administration | ORAL |
Packaging size | Blister pack of 6 Tablets |
ATC code | N02CC |
ATC description | ANTIMIGRAINE PREPARATIONS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2017-06-30 |
Remaining supply date | 2017-06-30 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6575 DAVAND DRIVE MISSISSAUGA, ONTARIO CANADA L5T 2M3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2017-07-01 | English | Compare |
v6 | 2017-06-21 | French | Compare |
v5 | 2017-06-21 | English | Compare |
v4 | 2017-06-21 | English | Compare |
v3 | 2017-06-21 | French | Compare |
v2 | 2017-06-21 | French | Compare |
v1 | 2017-06-21 | English | Compare |
Showing 1 to 7 of 7